Market Overview

FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter's Hyqvia ror Primary Immunodeficiency; Expects FDA Response In Q3

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS

Posted-In: News FDA

 

Related Articles (HALO + BAX)